Tekla Capital Management LLC Galera Therapeutics, Inc. Transaction History
Tekla Capital Management LLC
- $2.53 Billion
- Q2 2023
A detailed history of Tekla Capital Management LLC transactions in Galera Therapeutics, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 898,374 shares of GRTX stock, worth $125,772. This represents 0.11% of its overall portfolio holdings.
Number of Shares
898,374
Previous 898,374
-0.0%
Holding current value
$125,772
Previous $2.3 Million
21.88%
% of portfolio
0.11%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding GRTX
# of Institutions
38Shares Held
10.7MCall Options Held
10.3KPut Options Held
0-
Gsa Capital Partners LLP London, X03.63MShares$508,5670.04% of portfolio
-
Blackstone Inc New York, NY1.68MShares$235,0570.0% of portfolio
-
Abrdn PLC898KShares$125,7720.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3613KShares$85,8510.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA448KShares$62,7660.0% of portfolio
About Galera Therapeutics, Inc.
- Ticker GRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,821,600
- Market Cap $3.76M
- Description
- Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...